XPO1 and Hutchinson-Gilford progeria syndrome: In summary, we showed that pharmacological inhibition of CRM1 using selinexor is a feasible strategy to treat HGPS and demonstrated that the robust anti‐senescent activity of selinexor is exerted by recovering proper nucleocytoplasmic partition of proteins and inducing progerin clearance in HGPS fibroblasts.